要点人群接种新冠疫苗顺畅推动

KK免更新

要点人群接种新冠疫苗顺畅推动

2021-03-22 11:30:07

阅读（11787）

u7ecfu6d4eu65e5u62a5-u4e2du56fdu7ecfu6d4eu7f51u5317u4eac3u670821u65e5u8bafuff08u8bb0u8005u5434u4f73u4f73uff09u56fdu52a1u9662u8054u9632u8054u63a7u673au5236u4ecau5929u53ecu5f00u65b0u95fbu53d1u5e03u4f1au4ecbu7ecduff0cu5f53u524du56fdu5185u75abu60c5u9632u63a7u603bu4f53u4fddu6301u826fu597du6001u52bfuff0cu6211u56fdu91cdu70b9u4ebau7fa4u65b0u51a0u75abu82d7u63a5u79cdu5de5u4f5cu987au5229u63a8u8fdbuff0cu622au81f33u670820u65e524u65f6uff0cu5168u56fdu7d2fu8ba1u62a5u544au63a5u79cd7495.6u4e07u5242u6b21uff0cu4e0bu4e00u6b65u5168u56fdu5c06u5927u89c4u6a21u5f00u5c5560u5c81u4ee5u4e0au8001u5e74u4ebau7fa4u7684u75abu82d7u63a5u79cdu3002

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

","summary":"u7ecfu6d4eu65e5u62a5-u4e2du56fdu7ecfu6d4eu7f51u5317u4eac3u670821u65e5u8bafuff08u8bb0u8005u5434u4f73u4f73uff09u56fdu52a1u9662u8054u9632u8054u63a7u673au5236u4ecau5929u53ecu5f00u65b0u95fbu53d1u5e03u4f1au4ecbu7ecduff0cu5f53u524du56fdu5185u75abu60c5u9632u63a7u603bu4f53u4fddu6301u826fu597du6001u52bfuff0cu6211u56fdu91cdu70b9u4ebau7fa4u65b0u51a0u75abu82d7u63a5u79cdu5de5u4f5cu987au5229u63a8u8fdbuff0cu622au81f33u670820u65e524u65f6uff0cu5168u56fdu7d2fu8ba1u62a5u544au63a5u79cd7495.6u4e07u5242u6b21uff0cu4e0bu4e00u6b65u5168u56fdu5c06u5927u89c4u6a21u5f00u5c5560u5c81u4ee5u4e0au8001u5e74u4ebau7fa4u7684u75abu82d7u63a5u79cd","addltype":"normal","keywords":["u75abu82d7","u63a5u79cd","u4e0du826fu53cdu5e94","u65b0u51a0","60","u4ebau7fa4","u9632u63a7","u75abu60c5"],"subtitle":"u91cdu70b9u4ebau7fa4u63a5u79cdu65b0u51a0u75abu82d7u987au5229u63a8u8fdb","typedata":{"audio":{"members":[]},"video":{"members":[]},"gallery":{"members":[]}},"copyright":{"name":"","url":""},"ext-xtime":1616383766597,"isdeleted":false,"aid_number":"3389802448886514209","ext-weight":null,"keyboarder":{"name":"u7f57u751c","email":"luotian@huanqiu.com"},"ext-serious":1,"fingerprint":{"s0":"1e3a","s1":"049e","s2":"8163","s3":"0b54"},"ext-original":"","ext-relation":[],"ext-songshen":false,"ext-defertime":0,"ext-CommentStatus":true,"ext-phpcmsv9aid":0,"ext-status":0}"; var article = JSON.parse(cs_article); function escapeHtml(text) { var map = { '&': '&', '<': '<', '>': '>', '"': '"', "'": ''' }; return text.replace(/[&<>"']/g, function(m) { return map[m]; }); } var oKeywordArr=''; for(var oK in article.keywords) { oKeywordArr+=escapeHtml(article.keywords[oK])+','; } window.onload = function(){ //$('#meta-k').attr('content', escapeHtml(article.keywords.join(',')).replace(/[rn]/g,"")); $('#meta-k').attr('content', oKeywordArr.substring(0, oKeywordArr.lastIndexOf(','))); // if(article.summary!=null) // { // $("#meta-d").attr('content',escapeHtml(article.summary)); // } $("#meta-d").attr('content',escapeHtml(article.summary)); } function getURL0(name) { var reg = new RegExp("(^ &)" + name + "=([^&]*)(& $)"); var r = decodeURIComponent(window.location.search).substr(1).match(reg); if (r != null) return unescape(r[2]); return null; }; function getCookieFn(key){var name=key+"=";var ca=document.cookie.split(";");for(var i=0;i

要点人群接种新冠疫苗重庆侦探顺利推动

来历：经济日报

2021-03-22 11:29

经济日报-我国经济网北京3月21日讯（记者吴佳佳）国务院联防联控机制今日举行新闻发布会介绍，当时国内疫情防控整体坚持杰出态势，我国要点人群新冠疫苗接种工作顺利推动，到3月20日24时，全国累计陈述接种7495.6万剂次，下一步全国将大规模展开60岁以上晚年人群的疫苗接种。

国家卫健委宣传司副司长、新闻发言人重庆侦探米锋指出，各地正在全面抓好常态化疫情防控，确保大众安全、顺利出行。当时，国内低危险区域持健康通行"绿码"，在测温正常且做好个人防护的前提下可有序出行，各地不得私行加码。对新增发出病例，要发现一同、熄灭一同，确保不呈现规模性反弹。

关于60岁以上人群新冠疫苗接种的状况，国家卫生健康委员会疾控局一级巡视员贺青华在会上表明，部分区域在充沛评价健康状况的状况下和被感染危险的前提下，现已开端为60岁以上身体条件比较好的白叟接种新冠疫苗。一起，疫苗研制单位也在加速推动研制，在临床试验获得满意安全性、有效性数据今后，将大规模展开60岁以上晚年人群的疫苗接种。

已然疫苗需求大规模接种，那么产值怎么确保？工业和信息化部消费品工业司副司长毛俊锋表明，现在疫苗产值与2月初比较现已有了大幅度进步，下一步还会进一步提高。全年疫苗产值完全能够满意全国人民的接种需求。现在，我国已有5款疫苗获批了附条件上市或者是获准了紧迫运用，其他技能道路的疫苗也会连续上市，一旦产品获批，就会发动出产、上市供给。

"疫苗出产周期长，触及环节多，技能含量更高，特别是对它的监管要求也更为严厉，尤其是新冠病毒疫苗，现在疫苗出产总量、扩产增产速度在我国都是史无前例的，企业在增产扩能过程中要一直把质量安全放在第一位。"毛俊锋说，企业要实在实行疫苗质量安全的主体职责，严厉执行质量管理体系。

针对国产疫苗不良反响状况，我国疾控中心免疫规划首席专家王华庆介绍，现在监测的不良反响首要包含部分反响和全身反响。部分的不良反响包含如痛苦、红肿、硬结的状况，这些无须处理，会自行康复；全身的不良反响包含如头痛、乏力、低热的状况。他介绍，当时接到的不良反响陈述为疑似不良反响，也就是说，归于置疑和疫苗有关的反响。后续将持续展开较为重庆侦探严峻的不良反响查询，经过弥补查询、了解接种史、疾病状况等，再由专家组做出确诊。

不少人关怀，接种疫苗后能够摘下口罩吗？对此，我国疾控中心副主任冯子健说，因为当时全球新冠疫情仍在持续盛行，国内疫苗接种率较低，来自高盛行区域的人员或物品入境重庆侦探，仍有导致在境内传达的危险。因而，我国在人群疫苗接种到达较高免疫水平之前，不管是否接种疫苗，在人群集合的室内或关闭场所，依然需求持续佩带口罩，并严厉遵从当地详细的防控办法要求。

来源:版权归属原作者,部分文章推送时未能及时与原作者取得联系,若来源标注错误或侵犯到您的权益烦请告知，我们会及时删除。

赞 29 收藏